UBS Cuts Price Target on Coca-Cola European Partners (CCE) to $38 Following 3Q
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
UBS maintained a Neutral rating on Coca-Cola European Partners (NYSE: CCE), and cut the price target to $38.00 (from $41.00), following the company's 3Q earnings report. Across the board, CCEP was able to grow its portfolio as Sparkling brands grew +3.0% (with Coca-Cola trademark up +2.0%), sparking flavours and energy grew +6.5%, and stills grew +4.0%. EPS was reported at €0.66, slightly ahead of the consensus of €0.65. Revenues were flat.
Analyst Stephen Powers commented, "CCE delivered Q3 EPS of €0.66 (vs. UBSe/cons. of €0.63/€0.65) alongside flat revenues (vs. UBSe/cons. of -3.9%/-2.5%); however, organic growth was up +3.5% (vs. UBSe/cons. of +1.5%/+1.3%) driven entirely by volume growth (+3.5% vs. UBSe of +1.0%). The strongest regions included Iberia (+6.5%), N. Europe (+5.5%), and France (+1.0%) while Germany (-1.0%) underperformed and Great Britain was plagued by FX issues (-13.0%, but +3.0% organic). On the bottom line, EBIT margins slightly underperformed (+31 bps vs. UBSe of +50 bps). In addition to reiterating FY16 guidance of flat revenue and EPS of €1.86-€1.90, CCEP announced Damian Gammell will succeed John Brock as CEO just before calendar year end (12/28)."
Shares of Coca-Cola European Partners closed at $34.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Drexel Hamilton Raises Price Target on Workday (WDAY) Following 3Q Beat
- Mizuho Securities Adjusts Estimates Following Gap, Inc. (GPS) Comp Miss
- Jefferies Raises Price Target on US Physical Therapy (USPH) to $63 Following 12-Clinic Acquisition
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesUBS, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!